Lynn Bichajian
Physician
Summary
Safety profile of the benzodiazepine remimazolam for procedural sedation in higher risk patients (ASA III/IV): Results from a randomized clinical trial.
Randall Ostroff, Daniel Harris, Lynn Bichajian Andrew Wahlert, Gabriel Fox. Abstract accepted for presentation at Society for Ambulatory Anesthesia; to be presented as a poster in Phoenix, AZ on May 13, 2022.
Silvestri GA, Bichajian LH, Harris DJ, Fox GM. Sedation with intravenous remimazolam provides rapid onset, recovery and discharge readiness in bronchoscopy patients: results from a randomized clinical trial. Poster presented at the CHEST virtual annual meeting; October 17, 2021.
Ayad S, BichajianL, Wahlert A, Fox GM. Intravenous amisulpride provides rapid and durable treatment of established postoperative nausea and vomiting. Poster presented at Society for Ambulatory Anesthesia virtual annual meeting May 13, 2021.
Habib AS, Dunne TS, Bichajian LH, Fox GM. Pharmacokinetics of selective D2/D3 anatgonist IV amisulpride for postoperative nausea and vomiting: Elucidating effects in key neural circuits. Poster presented at the American Society of Health-System Pharmacists virtual annual meeting December 8, 2020.
Urman R, Bichajian L, Dunne T, Habdas B, Fox G. Transient Pharmacophysiologic Effects of Intravenous Amisulpride on Serum Prolactin During Management of Postoperative Nausea and Vomiting (PONV). Poster presented at the Society for Ambulatory Anesthesiologists virtual annual meeting June 6, 2020.
Bichajian L, Martens A, Fox GM. Intravenous amisulpride does not meaningfully prolong QT at doses effective in postoperative nausea and vomiting. Poster presented at the American Society of Anesthesiologists annual meeting. October 22, 2019; Orlando, Florida.
Bergese SD, Uribe A, Bichajian L, Ashburn C, Fox GM, Habib AS. Amisulpride is Effective for Rescue of Ambulatory Patients with Postoperative Nausea and Vomiting: Data from a Randomized, Placebo-Controlled, Phase III Study. Poster encored for presentation at the American Society of Anesthesiologists annual meeting. October 19, 2019; Orlando, Florida. Additional presentation of data at a separate session (invitation only) on October 19, 2019.
Bergese SD, Uribe A, Bichajian L, Ashburn C, Fox GM, Habib AS. Amisulpride is Effective for Rescue of Ambulatory Patients with Postoperative Nausea and Vomiting: Data from a Randomized, Placebo-Controlled, Phase III Study. Poster presented at the Society for Ambulatory Anesthesia. May 11th, 2019; Austin, TX. Awarded first prize after a presentation of the data to the conference.
Ayad S, Elsharkawy H, Bichajian L, Ashburn C, Fox G, Habib A. Amisulpride for the rescue treatment of postoperative nausea and vomiting in high-risk patients who failed prophylaxis: impact of risk factors and number of prophylactic agents on treatment success. Poster presented at the Annual Congress of Enhanced Recovery and Perioperative Medicine; April 26th, 2019; Washington, DC. Awarded second prize.
"New Advances in Neuromuscular Blockade." Presented at the Brigham and Women's Department of Anesthesia Annual Resident Lecture Series, Boston, MA, July 15, 1992.
Potter LT, Ballesteros LA, Bichajian LH, Ferendelli CA Fischer A, Hanchett HE, Zhang R. 1991. Evidence for paired M2 muscarinic receptors. Molecular Pharmacology.
Vuchinich RE, Tucker JA, and Harllee LM. 1988. Behavioral Assessment of Alcohol Dependence. Book chapter in G.A. Marlatt and D. Donovan (Eds.), Assessment of Addictive Behaviors: Behavioral, Cognitive, and Physiological Procedures. New York: Guilford.
Vuchinich RE, Tucker JA, and Harllee LM. 1986. Individual differences in the reliability of alcoholics' reports of drinking. Poster presented at the annual meeting of the American Psychological Association, Washington, D.C.
Vuchinich RE, Tucker JA, Harllee LM. Hoffman, S., and Schwartz, J., 1985. Reliability of reports of temporal patterning of drinking behavior by alcoholics. Poster presented at the annual meeting for the Advancement of Behavior Therapy, Houston, Texas.
Overview
27
27
years of professional experience
1
1
Certification
Work History
Medical Science Liaison, Medical Affairs
Acacia Pharma, Inc.
Indianapolis, IN
11.2018 - Current
Field-based role covering Mid-Atlantic region for small start-up biotech company. Responsibilities included supporting two branded acute care products: Barhemsys (amisulpride) and Byfavo ( remimazolam) both before FDA approval (approved in 2020) as well as post-approval. Worked closely with other two Mid-Atlantic leadership personnel (Regional Business Director and Director of National Accounts) to gain formulary approval of products and to stimulate usage of product post formulary approval. Duties included: 1) Medical Information (Medical Information Request Form organization and completion, creation of Standard Response Letters, and participation in Medical Review Committee); 2) Publication (creating, writing and submitting medical abstracts and when accepted creating posters to present at scientific meetings. 3) Supporting internal colleagues by education on products as well as being available for questions and consultation. 4) Attending scientific meetings to network with KOLs, impart information on products, stay on top of latest developments in field and present posters.
Senior Medical Science Liaison, Medical Affairs
Mallinckrodt Pharmaceuticals
Bedminster, NJ
02.2016 - 10.2018
Established and maintained peer-peer relationships with Key Opinion Leaders or KOLs within pain, anesthesia and surgery spaces (acute care/hospital space). Was responsible being medical and scientific expert on Ofirmev (IV acetaminophen), one of branded products. In this role was responsible for ensuring that Ofirmev was utilized effectively, served as scientific peer and resource within medical community and was scientific expert to internal colleagues. Was given extra responsibility (one of three MSLs) to be asked to cover three new hemostatic drugs which were launched in 2016-17, in addition to continuing with Ofirmev. Other responsibilities included giving scientific/medical presentations for advisory boards, focus groups, conferences, and inservices as well as training speakers. When asked,Took part in discussions with R&D due to pain and anesthesia expertise.
Medical Director
Transitions Home Health and Private Care Company
Fitchburg, MA
11.2015 - 02.2016
Senior medical administrative position at private home health care agency. Provided overall medical leadership for operations. Duties included providing medical direction and guidance for nursing and treatment staff and serving liaison to local medical staff. Assisted in developing policies and procedures and also monitored quality and appropriateness of medical care.
Staff Anesthesiologist and Partner
Anesthesia Associates of Massachusetts
Westwood, MA
09.2001 - 03.2015
Case load included general, ambulatory, vascular, thoracic, ENT, pediatric, obstetrical, orthopedic (including ultrasound-guided nerve blocks), urologic, neurosurgical, and acute pain service. Hospitals/surgicenters I was credentialed at included: St. Lukes Hospital in New Bedford, Hawthorne Ambulatory Surgical Center in Dartmouth (part of Steward), Beth Israel-Deaconess Glover Hospital in Needham, and Mount Auburn Hospital in Cambridge.
Staff Anesthesiologist and Clinical Instructor of Anesthesia at Harvard Medical School
Anesthesiologists of Mount Auburn
Cambridge, MA
09.1994 - 09.2001
Case load included general, ambulatory, cardiac, vascular, thoracic, obstetrical, ENT, orthopedic, urologic, neurosurgical, intensive care, and an acute pain service.
Education
Chief Resident of Anesthesia -
Brigham And Women's Hospital
Boston, MA1994
Residency in Anesthesia. -
Clinical Fellow of Anesthesia At Harvard Medical School And Resident of Anesthesia At Brigham And Women's Hospital
Boston, MA1994
Internship - Internal Medicine
University of Miami School of Medicine, Jackson Memorial Hospital
Miami, FL1991
M.D. - undefined
University of Miami School of Medicine
Miami, FL1990
Bachelor of Arts -
Cornell University College of Arts and Sciences
Ithaca, NY1984
Skills
- Proficient in Spanish and German
- Culturally sensitive
- Strong interpersonal skills
Certification
Board certification, American Board of Anesthesiology, 1995 (no re-certification required)
Currently taking a course for Advanced Physician Medical Monitoring Certification by CCRPS (Certified Clinical Research Professionals Society)
Professional Organizations
American Society of Anesthesiologists since 1991
Massachusetts Society of Anesthesiologists 1991-2018
Massachusetts Medical Society since 1994-2018
Virginia Society of Anesthesiologists since 2018
Society for Ambulatory Anesthesiologists since 2019
Timeline
Medical Science Liaison, Medical Affairs
Acacia Pharma, Inc.
11.2018 - Current
Senior Medical Science Liaison, Medical Affairs
Mallinckrodt Pharmaceuticals
02.2016 - 10.2018
Medical Director
Transitions Home Health and Private Care Company
11.2015 - 02.2016
Staff Anesthesiologist and Partner
Anesthesia Associates of Massachusetts
09.2001 - 03.2015
Staff Anesthesiologist and Clinical Instructor of Anesthesia at Harvard Medical School
Anesthesiologists of Mount Auburn
09.1994 - 09.2001
Chief Resident of Anesthesia -
Brigham And Women's Hospital
Residency in Anesthesia. -
Clinical Fellow of Anesthesia At Harvard Medical School And Resident of Anesthesia At Brigham And Women's Hospital
Internship - Internal Medicine
University of Miami School of Medicine, Jackson Memorial Hospital
M.D. - undefined
University of Miami School of Medicine
Bachelor of Arts -
Cornell University College of Arts and Sciences